A Rapid Review of the Effects of the COVID-19 Vaccine Among Individuals Taking Clozapine.

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Journal of Clinical Psychopharmacology Pub Date : 2024-04-19 DOI:10.1097/jcp.0000000000001854

Aparna Das, Amanda T Sawyer, Prabhava Bagla

引用次数: 0

Abstract

The COVID-19 pandemic prompted the rapid development of vaccines to combat the virus. Several COVID-19 vaccines have proven effective in preventing infection, hospitalization, and death. Vaccination has been especially recommended for vulnerable populations, such as individuals with psychiatric illnesses who face increased risks due to comorbidities and socioeconomic factors. This rapid review identifies and analyzes the effects of COVID-19 vaccines among individuals taking clozapine.

查看原文本刊更多论文

快速审查 COVID-19 疫苗对服用氯氮平患者的影响。

COVID-19 的大流行促使人们迅速开发疫苗来抗击该病毒。事实证明，多种 COVID-19 疫苗可有效预防感染、住院和死亡。特别推荐易感人群接种疫苗，如患有精神疾病的人，他们因合并症和社会经济因素而面临更大的风险。本快速综述确定并分析了 COVID-19 疫苗对服用氯氮平患者的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Psychopharmacology 医学-精神病学

CiteScore

4.00

自引率

3.40%

发文量

231

审稿时长

4-8 weeks

期刊介绍： Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.